NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Breaking the Chains of OCD: TMS Therapy Offers New Hope for Obsessive-Compulsive Disorder
Obsessive-Compulsive Disorder (OCD) affects millions of individuals worldwide, creating significant challenges in their daily lives. While traditional treatments such as [...]
TMS Therapy Is Revolutionizing Neurological Care
As a leader in neurological innovation, Countryside Neurology is at the forefront of harnessing the power of TMS therapy to [...]
TMS Therapy Beyond Depression: Exploring its Impact on Anxiety and Stress Management
In today's fast-paced world, anxiety and stress have become prevalent challenges affecting millions. While TMS therapy has long been recognized [...]
Pioneering Progress: Countryside Neurology’s Modern Approach to Neurological Care
At Countryside Neurology, we're dedicated to pushing the boundaries of neurology and embracing the latest advancements in medical science to [...]
Managing Numbness: Unraveling the Mystery
Experiencing numbness can be unsettling, but understanding its causes and seeking appropriate treatment can help you regain control and find [...]
Post-Stroke Rehabilitation: Your Path to Regaining Independence
Recovering from a stroke can be a challenging journey, but with the right support and guidance, it's possible to regain [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social